Posts

Psychedelic Business Spotlight – December 10

,
This week in psychedelic business news: Wesana Health files a new patent, Silo Pharma is granted a patent, and 2 companies explore a merger.
Psychedelic Business Spotlight: November 5

Psychedelic Business Spotlight: November 5

,
This week in psychedelic business news: DEA grants Cybin a Schedule I manufacturing license; PharmaTher partners with Revive Therapeutics on microneedle patch technology; Mydecine patents nanotechnology.
Psychedelic Business Spotlight: October 22

Psychedelic Business Spotlight: October 22

,
This week in psychedelic business news: UK fast tracks DMT for major depressive disorder; Field Trip Health expands its clinical presence in the US; and another psychedelic pharmaceuticals company...

Psychedelic Business Spotlight: October 15

,
This week in psychedelic business news: Cybin inhales; atai Life Sciences expands; DEA grants new psilocybin license; and FDA backs ketamine.
Psychedelic Business Spotlight: Big Week for Research and Clinical Trials

Psychedelic Business Spotlight: September 10, 2021

,
This week in psychedelic business news: major DMT development for stroke treatment; a propriety psilocybin formulation has potential to treat obesity; two more companies join the OTC Pink Market....

Algernon Pharmaceuticals Shows DMT Can Increase Neuron Growth by 40%

The Vancouver-based drug development company is investigating the use of DMT as a possible treatment for stroke.